Company / Return on Assets (ROA)
Catalyst Pharmaceuticals Partners, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
19.4%
FY2025
5-year range
15.2% / 22.1%
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
#11 of 213
Health Care
What the data says
Among 213 Health Care companies, Catalyst Pharmaceuticals Partners, Inc. is in the top 5% for return on assets (roa). Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -56.3% in FY2018 to 39.0% in FY2020.
Based on SEC 10-K filings.
19.4% in FY2025 with a 5-year CAGR of -19.6%. Top quartile in the Health Care sector.
Improved from 15.2% to 19.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -2.7pp
- 5-Year Change
- -19.6pp
- 10-Year Change
- -
Sector benchmark
+180.4% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 0.8% year-over-year.
- Currently 43.5pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 19.4% | +0.8% |
| FY2024 | 19.3% | +26.7% |
| FY2023 | 15.2% | -31.3% |
| FY2022 | 22.1% | +33.3% |
| FY2021 | 16.6% | -57.4% |
| FY2020 | 39.0% | +37.4% |
| FY2019 | 28.4% | +150.4% |
| FY2018 | -56.3% | -137.3% |
| FY2017 | -23.7% | +45.3% |
| FY2016 | -43.3% | -28.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026